As from May 10th 2007, Affärsstrategerna AB ser. B will be traded excluding the Innate Pharmaceuticals AB and AlphaHelix Molecular Diagnostics AB dividend. Terms: One share in Innate Pharmaceuticals AB will be received for every fiftieth ser. B share in Affärsstrategerna AB ser. B and one share in AlphaHelix Molecular Diagnostics AB will be received for every hundredth share in Affärsstrategerna AB ser. B Unchanged round lot: 5 000 Notice! This requires consent from the Annual General Meeting on May 9th, 2007.
Equities: Trading in Affärsstrategerna AB ser. B excluding the Innate Pharmaceuticals AB and AlphaHelix Molecular Diagnostics AB dividend (108/07)
| Source: Nasdaq Stockholm AB